{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:33:32Z","timestamp":1788780812448,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"French National Agency for Research on Aids and Viral Hepatitis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10461-021-03277-x","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T04:07:32Z","timestamp":1619496452000},"page":"4141-4153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study)"],"prefix":"10.1007","volume":"25","author":[{"given":"Tangui","family":"Barr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Merci\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8853-3829","authenticated-orcid":false,"given":"Fabienne","family":"Marcellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Esterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Duvivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Teicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Bureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Chas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Salmon-C\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Sogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Patrizia","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wittkop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Protopopescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ANRS CO13 HEPAVIH Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"issue":"2","key":"3277_CR1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0000000000000922","volume":"30","author":"LS Park","year":"2016","unstructured":"Park LS, Hern\u00e1ndez-Ram\u00edrez RU, Silverberg MJ, Crothers K, Dubrow R. Prevalence of non-HIV cancer risk factors in persons living with HIV\/AIDS: a meta-analysis. AIDS Lond Engl. 2016;30(2):273\u201391.","journal-title":"AIDS Lond Engl."},{"issue":"9","key":"3277_CR2","doi-asserted-by":"crossref","first-page":"e107451","DOI":"10.1371\/journal.pone.0107451","volume":"9","author":"L Tron","year":"2014","unstructured":"Tron L, Lert F, Spire B, Dray-Spira R. Tobacco smoking in HIV-infected versus general population in france: heterogeneity across the various groups of people living with HIV. PLoS ONE. 2014;9(9):e107451.","journal-title":"PLoS ONE"},{"key":"3277_CR3","unstructured":"Conseil national du SIDA et des h\u00e9patites virales (CNS), Agence nationale de recherche sur le sida et les h\u00e9patites virales (ANRS). Epid\u00e9miologie de l\u2019infection \u00e0 VIH en France (juillet 2017) [Epidemiology of HIV infection in France]. CNS\/ANRS. https:\/\/cns.sante.fr\/wp-content\/uploads\/2017\/10\/experts-vih_epidemio.pdf (2017). Accessed 10 June 2020"},{"key":"3277_CR4","first-page":"271","volume":"15","author":"R Andler","year":"2019","unstructured":"Andler R, Richard J-B, Guignard R, Quatrem\u00e8re G, Verrier F, Gane J, et al. Reduction of daily smoking rate among adults: results from the 2018 Sant\u00e9 Publique France health barometer. Bull Epid\u00e9miol Hebd. 2019;15:271\u20137.","journal-title":"Bull Epid\u00e9miol Hebd."},{"issue":"3 Suppl","key":"3277_CR5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1521\/aeap.2009.21.3_supp.106","volume":"21","author":"NR Reynolds","year":"2009","unstructured":"Reynolds NR. Cigarette smoking and hiv: more evidence for action. AIDS Educ Prev Off Publ Int Soc AIDS Educ. 2009;21(3 Suppl):106\u201321.","journal-title":"AIDS Educ Prev Off Publ Int Soc AIDS Educ."},{"issue":"1\u20132","key":"3277_CR6","first-page":"61","volume":"36","author":"MM Marshall","year":"2010","unstructured":"Marshall MM, Kirk GD, Caporaso NE, McCormack MC, Merlo CA, Hague JC, et al. Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users. Addict Behav. 2010;36(1\u20132):61\u20137.","journal-title":"Addict Behav."},{"issue":"8","key":"3277_CR7","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/10826080500514503","volume":"41","author":"DJ McKirnan","year":"2006","unstructured":"McKirnan DJ, Tolou-Shams M, Turner L, Dyslin K, Hope B. Elevated risk for tobacco use among men who have sex with men is mediated by demographic and psychosocial variables. Subst Use Misuse. 2006;41(8):1197\u2013208.","journal-title":"Subst Use Misuse"},{"issue":"12","key":"3277_CR8","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/jvh.13380","volume":"27","author":"T Barr\u00e9","year":"2020","unstructured":"Barr\u00e9 T, Nishimwe ML, Protopopescu C, Marcellin F, Carrat F, Dorival C, et al. Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort). J Viral Hepat. 2020;27(12):1473\u201383.","journal-title":"J Viral Hepat."},{"issue":"6","key":"3277_CR9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.amjmed.2018.01.011","volume":"131","author":"RS Kim","year":"2018","unstructured":"Kim RS, Weinberger AH, Chander G, Sulkowski MS, Norton B, Shuter J. Cigarette smoking in persons living with hepatitis C: the National Health and Nutrition Examination Survey (NHANES), 1999\u20132014. Am J Med. 2018;131(6):669\u201375.","journal-title":"Am J Med."},{"issue":"7","key":"3277_CR10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1089\/aid.2014.0284","volume":"31","author":"KW Chew","year":"2015","unstructured":"Chew KW, Bhattacharya D, McGinnis KA, Horwich TB, Tseng C-H, Currier JS, et al. Short communication: coronary heart disease risk by framingham risk score in hepatitis C and HIV\/Hepatitis C-coinfected persons. AIDS Res Hum Retroviruses. 2015;31(7):718\u201322.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3277_CR11","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/add.13851","volume":"112","author":"R Knight","year":"2017","unstructured":"Knight R, Roux P, Vilotitch A, Marcellin F, Rosenthal E, Esterle L, et al. Significant reductions in alcohol use after Hepatitis C treatment: results from the French ANRS CO13-HEPAVIH cohort: significant reductions in alcohol use. Addiction. 2017;112:1669.","journal-title":"Addiction"},{"issue":"9","key":"3277_CR12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/13548506.2017.1280177","volume":"22","author":"R Fialho","year":"2017","unstructured":"Fialho R, Pereira M, Rusted J, Whale R. Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis. Psychol Health Med. 2017;22(9):1089\u2013104.","journal-title":"Psychol Health Med."},{"issue":"1","key":"3277_CR13","first-page":"65","volume":"35","author":"P Cacoub","year":"2015","unstructured":"Cacoub P, Dabis F, Costagliola D, Almeida K, Lert F, Piroth L, et al. Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France. Liver Int Off J Int Assoc Study Liver. 2015;35(1):65\u201370.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"Suppl 3","key":"3277_CR14","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1097\/01.aids.0000192090.61753.d4","volume":"19","author":"H Hagan","year":"2005","unstructured":"Hagan H, Thiede H, Des Jarlais DC. HIV\/hepatitis C virus co-infection in drug users: risk behavior and prevention. AIDS Lond Engl. 2005;19(Suppl 3):S199-207.","journal-title":"AIDS Lond Engl."},{"key":"3277_CR15","first-page":"17","volume":"8","author":"W Kariuki","year":"2015","unstructured":"Kariuki W, Manuel JI, Kariuki N, Tuchman E, O\u2019Neal J, Lalanne GA. HIV and smoking: associated risks and prevention strategies. HIVAIDS (Auckland, NZ). 2015;8:17\u201336.","journal-title":"HIVAIDS (Auckland, NZ)"},{"issue":"9635","key":"3277_CR16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","volume":"372","author":"Antiretroviral Therapy Cohort Collaboration","year":"2008","unstructured":"Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet Lond Engl. 2008;372(9635):293\u20139.","journal-title":"Lancet Lond Engl."},{"issue":"8","key":"3277_CR17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/QAD.0000000000000222","volume":"28","author":"P Morlat","year":"2014","unstructured":"Morlat P, Roussillon C, Henard S, Salmon D, Bonnet F, Cacoub P, et al. Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000. AIDS Lond Engl. 2014;28(8):1181\u201391.","journal-title":"AIDS Lond Engl."},{"issue":"2","key":"3277_CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/QAD.0000000000000540","volume":"29","author":"M Helleberg","year":"2015","unstructured":"Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, F\u00e4tkenheuer G, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS Lond Engl. 2015;29(2):221\u20139.","journal-title":"AIDS Lond Engl."},{"issue":"10107","key":"3277_CR19","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/S0140-6736(17)32460-1","volume":"390","author":"C Gartner","year":"2017","unstructured":"Gartner C, Miller A, Bonevski B. Extending survival for people with hepatitis C using tobacco dependence treatment. Lancet. 2017;390(10107):2033.","journal-title":"Lancet"},{"issue":"6","key":"3277_CR20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/QAD.0000000000002156","volume":"33","author":"N Kronfli","year":"2019","unstructured":"Kronfli N, Bhatnagar SR, Hull MW, Moodie EEM, Cox J, Walmsley S, et al. Trends in cause-specific mortality in HIV\u2013hepatitis C coinfection following hepatitis C treatment scale-up. AIDS. 2019;33(6):1013.","journal-title":"AIDS"},{"key":"3277_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugpo.2019.05.011","volume":"72","author":"M Caven","year":"2019","unstructured":"Caven M, Malaguti A, Robinson E, Fletcher E, Dillon JF. Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: a systematic review. Int J Drug Policy. 2019;72:169\u201376.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"3277_CR22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1179\/501100000024","volume":"16","author":"MW Yeung","year":"2015","unstructured":"Yeung MW, Young J, Moodie E, Rollet-Kurhajec KC, Schwartzman K, Greenaway C, et al. Changes in quality of life, healthcare use, and substance use in HIV\/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study. HIV Clin Trials. 2015;16(3):100\u201310.","journal-title":"HIV Clin Trials"},{"key":"3277_CR23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2334-10-303","volume":"10","author":"M-A Loko","year":"2010","unstructured":"Loko M-A, Salmon D, Carrieri P, Winnock M, Mora M, Merchadou L, et al. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006\u20132010. BMC Infect Dis. 2010;10:303.","journal-title":"BMC Infect Dis."},{"issue":"35","key":"3277_CR24","first-page":"38","volume":"2004","author":"D Prentiss","year":"1999","unstructured":"Prentiss D, Power R, Balmas G, Tzuang G, Israelski D. Patterns of marijuana use among patients with HIV\/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr. 1999;2004(35):38\u201345.","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"10","key":"3277_CR25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/01.meg.0000236869.93527.b9","volume":"18","author":"B Fischer","year":"2006","unstructured":"Fischer B, Reimer J, Firestone M, Kalousek K, Rehm J, Heathcote J. Treatment for hepatitis C virus and cannabis use in illicit drug user patients: implications and questions. Eur J Gastroenterol Hepatol. 2006;18(10):1039\u201342.","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"4","key":"3277_CR26","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s10461-019-02585-7","volume":"24","author":"ME Santos","year":"2020","unstructured":"Santos ME, Protopopescu C, Sogni P, Yaya I, Piroth L, Bailly F, et al. HCV-related mortality among HIV\/HCV co-infected patients: the importance of behaviors in the HCV cure era (ANRS CO13 HEPAVIH Cohort). AIDS Behav. 2020;24(4):1069\u201384.","journal-title":"AIDS Behav."},{"key":"3277_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2016.00104\/full","author":"C Hindocha","year":"2016","unstructured":"Hindocha C, Freeman TP, Ferris JA, Lynskey MT, Winstock AR. No smoke without tobacco: a Global overview of cannabis and tobacco routes of administration and their association with intention to quit. Front Psychiatry. 2016. https:\/\/doi.org\/10.3389\/fpsyt.2016.00104\/full.","journal-title":"Front Psychiatry"},{"issue":"6","key":"3277_CR28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"3","key":"3277_CR29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385\u2013401.","journal-title":"Appl Psychol Meas."},{"issue":"3","key":"3277_CR30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S0767399X00001590","volume":"4","author":"R Fuhrer","year":"1989","unstructured":"Fuhrer R, Rouillon F. La version fran\u00e7aise de l\u2019\u00e9chelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l\u2019\u00e9chelle d\u2019auto\u00e9valuation. Psychiatr Psychobiol. 1989;4(3):163\u20136.","journal-title":"Psychiatr Psychobiol."},{"issue":"3","key":"3277_CR31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/hiv.12571","volume":"19","author":"E Rosenthal","year":"2018","unstructured":"Rosenthal E, Fougerou-Leurent C, Renault A, Carrieri MP, Marcellin F, Garraffo R, et al. Efficacy, safety and patient-reported outcomes of ledipasvir\/sofosbuvir in NS3\/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study). HIV Med. 2018;19(3):227\u201337.","journal-title":"HIV Med."},{"issue":"Suppl 1","key":"3277_CR32","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0895-4356(01)00449-8","volume":"54","author":"AC Justice","year":"2001","unstructured":"Justice AC, Holmes W, Gifford AL, Rabeneck L, Zackin R, Sinclair G, et al. Development and validation of a self-completed HIV Symptom Index. J Clin Epidemiol. 2001;54(Suppl 1):S77.","journal-title":"J Clin Epidemiol."},{"issue":"16","key":"3277_CR33","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","volume":"158","author":"K Bush","year":"1998","unstructured":"Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med. 1998;158(16):1789\u201395.","journal-title":"Arch Intern Med."},{"key":"3277_CR34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2307\/270718","volume":"13","author":"PD Allison","year":"1982","unstructured":"Allison PD. Discrete-time methods for the analysis of event histories. Sociol Methodol. 1982;13:61\u201398.","journal-title":"Sociol Methodol."},{"issue":"4","key":"3277_CR35","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.gastro.2018.11.022","volume":"156","author":"AA Butt","year":"2019","unstructured":"Butt AA, Yan P, Shuaib A, Abou-Samra A-B, Shaikh OS, Freiberg MS. Direct-acting antiviral therapy for HCV infection is associated with a reduced risk of cardiovascular disease events. Gastroenterology. 2019;156(4):987-996.e8.","journal-title":"Gastroenterology"},{"key":"3277_CR36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.drugpo.2017.05.040","volume":"47","author":"H Midgard","year":"2017","unstructured":"Midgard H, Hajarizadeh B, Cunningham E, Conway B, Backmund M, Bruggmann P, et al. Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: the ACTIVATE study. Int J Drug Policy. 2017;47:230.","journal-title":"Int J Drug Policy"},{"issue":"10","key":"3277_CR37","doi-asserted-by":"crossref","first-page":"e0205277","DOI":"10.1371\/journal.pone.0205277","volume":"13","author":"R Juanbeltz","year":"2018","unstructured":"Juanbeltz R, Mart\u00ednez-Baz I, Miguel RS, Go\u00f1i-Esarte S, Cabas\u00e9s JM, Castilla J. Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients. PLoS ONE. 2018;13(10):e0205277.","journal-title":"PLoS ONE"},{"issue":"10","key":"3277_CR38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3748\/wjg.v12.i10.1545","volume":"12","author":"L Castera","year":"2006","unstructured":"Castera L, Constant A, Bernard P-H, de Ledinghen V, Couzigou P. Psychological impact of chronic hepatitis C: comparison with other stressful life events and chronic diseases. World J Gastroenterol. 2006;12(10):1545\u201350.","journal-title":"World J Gastroenterol."},{"issue":"3","key":"3277_CR39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0306-4603(85)90002-4","volume":"10","author":"AD Revell","year":"1985","unstructured":"Revell AD, Warburton DM, Wesnes K. Smoking as a coping strategy. Addict Behav. 1985;10(3):209\u201324.","journal-title":"Addict Behav."},{"issue":"10","key":"3277_CR40","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/ntr\/ntp120","volume":"11","author":"JA Fidler","year":"2009","unstructured":"Fidler JA, West R. Self-perceived smoking motives and their correlates in a general population sample. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2009;11(10):1182\u20138.","journal-title":"Nicotine Tob Res Off J Soc Res Nicotine Tob.."},{"key":"3277_CR41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2015.06.007","volume":"153","author":"A Batchelder","year":"2015","unstructured":"Batchelder A, Peyser D, Nahvi S, Arnsten J, Litwin A. \u201cHepatitis C treatment turned me around:\u201d psychological and behavioral transformation related to hepatitis C treatment. Drug Alcohol Depend. 2015;153:66\u201371.","journal-title":"Drug Alcohol Depend."},{"key":"3277_CR42","doi-asserted-by":"crossref","unstructured":"Torrens M, Soyemi T, Bowman D, Schatz E. Beyond clinical outcomes: the social and healthcare system implications of hepatitis C treatment. BMC Infect Dis. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7517680\/ (2020). Accessed 29 Oct 2020","DOI":"10.1186\/s12879-020-05426-4"},{"key":"3277_CR43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.drugpo.2019.03.015","volume":"72","author":"EB Williams","year":"2019","unstructured":"Williams EB, Nelons D, Seaman A, Witkowska M, Ronan W, Wheelock H, et al. Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs. Int J Drug Policy. 2019;72:138\u201345.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"3277_CR44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.psym.2017.07.003","volume":"58","author":"M Janda","year":"2017","unstructured":"Janda M, Mergenhagen KA. The effect of psychosocial factors on success rates of hepatitis C treatment. Psychosomatics. 2017;58(6):624\u201332.","journal-title":"Psychosomatics"},{"issue":"5","key":"3277_CR45","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/ntr\/ntv144","volume":"18","author":"MA de Dios","year":"2016","unstructured":"de Dios MA, Stanton CA, Cano M\u00c1, Lloyd-Richardson E, Niaura R. The influence of social support on smoking cessation treatment adherence among HIV+ smokers. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2016;18(5):1126\u201333.","journal-title":"Nicotine Tob Res Off J Soc Res Nicotine Tob."},{"issue":"4","key":"3277_CR46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1017\/jsc.2017.26","volume":"13","author":"JN Soulakova","year":"2018","unstructured":"Soulakova JN, Tang C-Y, Leonardo SA, Taliaferro LA. Motivational benefits of social support and behavioural interventions for smoking cessation. J Smok Cessat. 2018;13(4):216\u201326.","journal-title":"J Smok Cessat."},{"issue":"4","key":"3277_CR47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/108729104323038919","volume":"18","author":"OM Adeyemi","year":"2004","unstructured":"Adeyemi OM, Jensen D, Attar B, Ghaoui R, Gallagher M, Wolen D, et al. Hepatitis C treatment eligibility in an urban population with and without HIV coinfection. AIDS Patient Care STDs. 2004;18(4):239\u201345.","journal-title":"AIDS Patient Care STDs"},{"issue":"1","key":"3277_CR48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41124-016-0011-y","volume":"1","author":"JF Dillon","year":"2016","unstructured":"Dillon JF, Lazarus JV, Razavi HA. Urgent action to fight hepatitis C in people who inject drugs in Europe. Hepatol Med Policy. 2016;1(1):2.","journal-title":"Hepatol Med Policy"},{"issue":"6","key":"3277_CR49","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1007\/s10620-017-4548-4","volume":"62","author":"JB Dever","year":"2017","unstructured":"Dever JB, Ducom JH, Ma A, Nguyen J, Liu L, Herrin A, et al. Engagement in care of high-risk hepatitis C patients with interferon-free direct-acting antiviral therapies. Dig Dis Sci. 2017;62(6):1472\u20139.","journal-title":"Dig Dis Sci."},{"key":"3277_CR50","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/QAI.0000000000002284","volume":"83","author":"GV De Socio","year":"2020","unstructured":"De Socio GV, Ricci E, Maggi P, Orofino G, Squillace N, Menzaghi B, et al. Is it feasible to impact on smoking habits in HIV-Infected patients? Mission impossible from the STOPSHIV Project cohort. J Acquir Immune Defic Syndr 1999. 2020;83:496.","journal-title":"J Acquir Immune Defic Syndr. 1999"},{"issue":"12","key":"3277_CR51","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/ntr\/ntx212","volume":"20","author":"JM Wray","year":"2018","unstructured":"Wray JM, Funderburk JS, Acker JD, Wray LO, Maisto SA. A meta-analysis of brief tobacco interventions for use in integrated primary care. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2018;20(12):1418\u201326.","journal-title":"Nicotine Tob Res Off J Soc Res Nicotine Tob."},{"issue":"4","key":"3277_CR52","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s10461-008-9449-2","volume":"14","author":"JM Tesoriero","year":"2010","unstructured":"Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14(4):824\u201335.","journal-title":"AIDS Behav."},{"issue":"1","key":"3277_CR53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1617-9625-12-2","volume":"12","author":"M Bains","year":"2014","unstructured":"Bains M, Britton J, Marsh J, Jayes L, Murray RL. Patients\u2019 and healthcare professionals\u2019 views on a specialist smoking cessation service delivered in a United Kingdom hospital: a qualitative study. Tob Induc Dis. 2014;12(1):2.","journal-title":"Tob Induc Dis."},{"issue":"6","key":"3277_CR54","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/ajad.12259","volume":"24","author":"M Khara","year":"2015","unstructured":"Khara M, Okoli C, Nagarajan VD, Aziz F, Hanley C. Smoking cessation outcomes of referral to a specialist hospital outpatient clinic. Am J Addict. 2015;24(6):561\u201370.","journal-title":"Am J Addict."},{"issue":"7","key":"3277_CR55","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/apc.2006.0142","volume":"21","author":"A Benard","year":"2007","unstructured":"Benard A, Bonnet F, Tessier J-F, Fossoux H, Dupon M, Mercie P, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDs. 2007;21(7):458\u201368.","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"3277_CR56","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s10461-019-02535-3","volume":"24","author":"SK Edwards","year":"2020","unstructured":"Edwards SK, Dean J, Power J, Baker P, Gartner C. Understanding the prevalence of smoking among people living with HIV (PLHIV) in Australia and factors associated with smoking and quitting. AIDS Behav. 2020;24(4):1056\u201363.","journal-title":"AIDS Behav."},{"issue":"1","key":"3277_CR57","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/tobaccocontrol-2018-054590","volume":"29","author":"AH Weinberger","year":"2020","unstructured":"Weinberger AH, Pacek LR, Wall MM, Gbedemah M, Lee J, Goodwin RD. Cigarette smoking quit ratios among adults in the USA with cannabis use and cannabis use disorders, 2002\u20132016. Tob Control. 2020;29(1):74\u201380.","journal-title":"Tob Control"},{"key":"3277_CR58","doi-asserted-by":"crossref","first-page":"107756","DOI":"10.1016\/j.drugalcdep.2019.107756","volume":"206","author":"S Voci","year":"2020","unstructured":"Voci S, Zawertailo L, Baliunas D, Masood Z, Selby P. Is cannabis use associated with tobacco cessation outcome? An observational cohort study in primary care. Drug Alcohol Depend. 2020;206:107756.","journal-title":"Drug Alcohol Depend."},{"issue":"13","key":"3277_CR59","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/QAD.0000000000000377","volume":"28","author":"MB Klein","year":"2014","unstructured":"Klein MB, Rollet-Kurhajec KC, Moodie EEM, Yaphe S, Tyndall M, Walmsley S, et al. Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003\u20132013). AIDS Lond Engl. 2014;28(13):1957\u201365.","journal-title":"AIDS Lond Engl."},{"issue":"7","key":"3277_CR60","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1360-0443.2012.03837.x","volume":"107","author":"A Agrawal","year":"2012","unstructured":"Agrawal A, Budney AJ, Lynskey MT. The co-occurring use and misuse of cannabis and tobacco: a review. Addict Abingdon Engl. 2012;107(7):1221\u201333.","journal-title":"Addict Abingdon Engl."},{"issue":"3","key":"3277_CR61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1037\/pha0000244","volume":"27","author":"EA McClure","year":"2019","unstructured":"McClure EA, Tomko RL, Salazar CA, Akbar SA, Squeglia LM, Herrmann E, et al. Tobacco and cannabis co-use: drug substitution, quit interest, and cessation preferences. Exp Clin Psychopharmacol. 2019;27(3):265\u201375.","journal-title":"Exp Clin Psychopharmacol."},{"key":"3277_CR62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.drugalcdep.2018.02.037","volume":"187","author":"L Dierker","year":"2018","unstructured":"Dierker L, Braymiller J, Rose J, Goodwin R, Selya A. Nicotine dependence predicts cannabis use disorder symptoms among adolescents and young adults. Drug Alcohol Depend. 2018;187:212\u201320.","journal-title":"Drug Alcohol Depend."},{"issue":"5\u20136","key":"3277_CR63","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","volume":"13","author":"C Cohen","year":"2002","unstructured":"Cohen C, Perrault G, Voltz C, Steinberg R, Soubri\u00e9 P. SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol. 2002;13(5\u20136):451\u201363.","journal-title":"Behav Pharmacol."},{"issue":"2","key":"3277_CR64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/ajad.12186","volume":"24","author":"RA Rabin","year":"2015","unstructured":"Rabin RA, George TP. A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use. Am J Addict. 2015;24(2):105\u201316.","journal-title":"Am J Addict."},{"issue":"2","key":"3277_CR65","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s11065-016-9316-2","volume":"26","author":"F Ganzer","year":"2016","unstructured":"Ganzer F, Br\u00f6ning S, Kraft S, Sack P-M, Thomasius R. Weighing the evidence: a systematic review on long-term neurocognitive effects of Cannabis use in abstinent adolescents and adults. Neuropsychol Rev. 2016;26(2):186\u2013222.","journal-title":"Neuropsychol Rev."},{"issue":"6","key":"3277_CR66","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/17460441.2014.908180","volume":"9","author":"RL Ashare","year":"2014","unstructured":"Ashare RL, Schmidt HD. Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal. Expert Opin Drug Discov. 2014;9(6):579\u201394.","journal-title":"Expert Opin Drug Discov."},{"issue":"5","key":"3277_CR67","doi-asserted-by":"crossref","first-page":"e537","DOI":"10.4088\/JCP.16m10657","volume":"78","author":"SE McCabe","year":"2017","unstructured":"McCabe SE, West BT. The three-year course of multiple substance use disorders in the United States: a National Longitudinal Study. J Clin Psychiatry. 2017;78(5):e537\u201344.","journal-title":"J Clin Psychiatry"},{"key":"3277_CR68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addbeh.2016.10.012","volume":"65","author":"K McKelvey","year":"2017","unstructured":"McKelvey K, Thrul J, Ramo D. Impact of quitting smoking and smoking cessation treatment on substance use outcomes: an updated and narrative review. Addict Behav. 2017;65:161\u201370.","journal-title":"Addict Behav."},{"issue":"11","key":"3277_CR69","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3109\/10826084.2016.1170145","volume":"51","author":"MS Subbaraman","year":"2016","unstructured":"Subbaraman MS. Substitution and complementarity of alcohol and Cannabis: a review of the literature. Subst Use Misuse. 2016;51(11):1399\u2013414.","journal-title":"Subst Use Misuse"},{"key":"3277_CR70","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugalcdep.2014.01.022","volume":"138","author":"DJ Allsop","year":"2014","unstructured":"Allsop DJ, Dunlop AJ, Saddler C, Rivas GR, McGregor IS, Copeland J. Changes in cigarette and alcohol use during cannabis abstinence. Drug Alcohol Depend. 2014;138:54\u201360.","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"3277_CR71","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.psc.2012.03.010","volume":"35","author":"F Ducci","year":"2012","unstructured":"Ducci F, Goldman D. The genetic basis of addictive disorders. Psychiatr Clin North Am. 2012;35(2):495\u2013519.","journal-title":"Psychiatr Clin North Am."},{"issue":"1","key":"3277_CR72","first-page":"7","volume":"51","author":"M Loflin","year":"2015","unstructured":"Loflin M, Earleywine M. No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk. Can J Respir Ther CJRT Rev Can Th\u00e9rapie Respir RCTR. 2015;51(1):7\u20139.","journal-title":"Can J Respir Ther CJRT Rev Can Th\u00e9rapie Respir RCTR"},{"key":"3277_CR73","doi-asserted-by":"crossref","unstructured":"Lanz C, Mattsson J, Soydaner U, Brenneisen R. Medicinal Cannabis: In Vitro Validation of vaporizers for the smoke-free inhalation of Cannabis. PLoS ONE 11(1). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4718604\/ (2016). Accessed 8 Sept 2020","DOI":"10.1371\/journal.pone.0147286"},{"issue":"1","key":"3277_CR74","doi-asserted-by":"crossref","first-page":"e0190768","DOI":"10.1371\/journal.pone.0190768","volume":"13","author":"JM Trigo","year":"2018","unstructured":"Trigo JM, Soliman A, Quilty LC, Fischer B, Rehm J, Selby P, et al. Nabiximols combined with motivational enhancement\/cognitive behavioral therapy for the treatment of cannabis dependence: a pilot randomized clinical trial. PLoS ONE. 2018;13(1):e0190768.","journal-title":"PLoS ONE"},{"key":"3277_CR75","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jamainternmed.2019.1993","volume":"179","author":"N Lintzeris","year":"2019","unstructured":"Lintzeris N, Bhardwaj A, Mills L, Dunlop A, Copeland J, McGregor I, et al. Nabiximols for the treatment of Cannabis dependence: a randomized clinical trial. JAMA Intern Med. 2019;179:1242.","journal-title":"JAMA Intern Med."},{"key":"3277_CR76","doi-asserted-by":"crossref","first-page":"108220","DOI":"10.1016\/j.drugalcdep.2020.108220","volume":"215","author":"N Lintzeris","year":"2020","unstructured":"Lintzeris N, Mills L, Dunlop A, Copeland J, Mcgregor I, Bruno R, et al. Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: results from a placebo-controlled randomised trial. Drug Alcohol Depend. 2020;215:108220.","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"3277_CR77","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1513\/pats.201009-058WR","volume":"8","author":"S Rahmanian","year":"2011","unstructured":"Rahmanian S, Wewers ME, Koletar S, Reynolds N, Ferketich A, Diaz P. Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc. 2011;8(3):313\u20139.","journal-title":"Proc Am Thorac Soc."},{"issue":"3","key":"3277_CR78","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2174\/157016210791111089","volume":"8","author":"G Encrenaz","year":"2010","unstructured":"Encrenaz G, B\u00e9nard A, Rondeau V, Bonnet F, Lazaro E, Neau D, et al. Determinants of smoking cessation attempts among HIV-infected patients results from a hospital-based prospective cohort. Curr HIV Res. 2010;8(3):212\u20137.","journal-title":"Curr HIV Res."},{"issue":"5","key":"3277_CR79","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/09540121.2017.1382678","volume":"30","author":"AH Weinberger","year":"2018","unstructured":"Weinberger AH, Seng EK, Esan H, Shuter J. Perceived risks and benefits of quitting smoking in a sample of adults living with HIV\/AIDS. AIDS Care. 2018;30(5):564\u20138.","journal-title":"AIDS Care"},{"issue":"6","key":"3277_CR80","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3851\/IMP1292","volume":"14","author":"P Peretti-Watel","year":"2009","unstructured":"Peretti-Watel P, Garelik D, Baron G, Spire B, Ravaud P, Duval X, et al. Smoking motivations and quitting motivations among HIV-infected smokers. Antivir Ther. 2009;14(6):781\u20137.","journal-title":"Antivir Ther."},{"key":"3277_CR81","doi-asserted-by":"crossref","unstructured":"Chaiton M, Diemert L, Cohen JE, Bondy SJ, Selby P, Philipneri A, et al. Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers. BMJ Open 6(6). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4908897\/ (2016). Accessed 14 Jan 2020","DOI":"10.1136\/bmjopen-2016-011045"},{"issue":"3","key":"3277_CR82","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1192\/bjp.bp.114.153494","volume":"207","author":"L Shahab","year":"2015","unstructured":"Shahab L, Gilchrist G, Hagger-Johnson G, Shankar A, West E, West R. Reciprocal associations between smoking cessation and depression in older smokers: findings from the English Longitudinal Study of Ageing. Br J Psychiatry J Ment Sci. 2015;207(3):243\u20139.","journal-title":"Br J Psychiatry J Ment Sci."},{"issue":"1","key":"3277_CR83","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1155\/2014\/301713","volume":"25","author":"GE Harris","year":"2014","unstructured":"Harris GE, Dupuis L, Mugford GJ, Johnston L, Haase D, Page G, et al. Patterns and correlates of cannabis use among individuals with HIV\/AIDS in Maritime Canada. Can J Infect Dis Med Microbiol. 2014;25(1):e1-7.","journal-title":"Can J Infect Dis Med Microbiol."},{"issue":"1","key":"3277_CR84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/jcm10010015","volume":"10","author":"D Hasin","year":"2020","unstructured":"Hasin D, Walsh C. Cannabis use, Cannabis use disorder, and comorbid psychiatric illness: a narrative review. J Clin Med. 2020;10(1):15.","journal-title":"J Clin Med."},{"issue":"2","key":"3277_CR85","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1521\/aeap.2018.30.2.169","volume":"30","author":"LR Pacek","year":"2018","unstructured":"Pacek LR, Towe SL, Hobkirk AL, Nash D, Goodwin RD. Frequency Of Cannabis use and medical cannabis use among persons living with HIV In The United States: findings from a nationally representative sample. AIDS Educ Prev Off Publ Int Soc AIDS Educ. 2018;30(2):169\u201381.","journal-title":"AIDS Educ Prev Off Publ Int Soc AIDS Educ."},{"key":"3277_CR86","doi-asserted-by":"crossref","unstructured":"Regan S, Meigs JB, Grinspoon SK, Triant VA. Determinants of Smoking and Quitting in HIV-Infected Individuals. PLoS ONE 21 11(4). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4839777\/ (2016). Accessed 7 Nov 2019","DOI":"10.1371\/journal.pone.0153103"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03277-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-021-03277-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03277-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T09:14:12Z","timestamp":1637226852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-021-03277-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":86,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3277"],"URL":"https:\/\/doi.org\/10.1007\/s10461-021-03277-x","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"19 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was designed and implemented in accordance with the Declaration of Helsinki, and the protocol was approved by the ethics Committee of the Cochin University Hospital in Paris.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}